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From quaternarization of quinuclidine enantiomers of 2-fluoro benzamide
LMA10203 in dichloromethane, the corresponding N-chloromethyl derivatives
LMA10227 and LMA10228 were obtained. Here, we compared the agonist action of
known zacopride and its 2-fluoro benzamide analogues, LMA10203, LMA10227 and
LMA10228 against mammalian homomeric α7 nicotinic acetylcholine receptor
expressed in Xenopus oocytes. We found that LMA10203 was a partial agonist of α7
receptor with a pEC50 value of 4.25±0.06μM whereas LMA10227 and LMA10228
were poorly active on α7 homomeric nicotinic receptor. LMA10227 and LMA10228
were identified as antagonists of acetylcholine-induced currents with IC50 values of
28.4μM and 39.3μM whereas LMA10203 and zacopride possessed IC50 values of
8.07μM and 7.04μM, respectively. Moreover, despite their IC50 values, LMA10227
was the most potent inhibitor of nicotine-induced current amplitudes (65.7±2.1%
inhibition). LMA10203 and LMA10228 had the same inhibitory effects (26.5±7.5%
and 33.2±4.1%, respectively), whereas zacopride had no significant inhibitory effect
(4.37±4%) on nicotine-induced responses. Our results revealed different
pharmacological properties between the four compounds on acetylcholine and
nicotine currents. The mode of action of benzamide compounds may need to be
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